Learn More
Medchemexpress LLC Cloperastine fendizoate | 85187-37-7 | 99.53% | 5 G

Supplier: Medchemexpress LLC HYB21795G
Cloperastine fendizoate is a potassium channel inhibitor that demonstrates concentration-dependent inhibition of hERG K+ currents. It is recognized for its antitussive (cough suppressing) and antiedemic properties, in addition to its ability to relax bronchial musculature. The compound also exhibits antihistaminic effects and a papaverine-like activity.
- Inhibits hERG K+ currents with an IC50 of 27 nM.
- Possesses antitussive and antiedemic activity.
- Relaxes bronchial musculature.
- Exhibits antihistaminic and papaverine-like activity.
- Has relatively low acute toxicity when administered orally (LD50 in rats and mice exceeds 2000 mg/kg).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.